Vascular Closure

Rapid hemostasis for arterial and venous access sites
Our portfolio of vascular closure products provides rapid hemostasis for interventional and electrophysiology procedures to help clinicians reduce the risk of complications, improve patient satisfaction, and enable same day discharge.

Request Information

Optimizing Vascular Access Management
• Enables same day discharge following AF ablation with VASCADE MVP^® Venous Vascular Closure System (VVCS)
• Reduces the risk of access site complications with VASCADE^® Vascular Closure System (VCS), as demonstrated in the RESPECT Clinical Trial¹
• Offers an outcomes-based risk-sharing VASCADE Performance Guarantee program – Sharing Risk by Sharing Costs

VASCADE®

The only closure device proven safer than manual compression in a randomized clinical trial with zero major complications.^1,2

Learn More

VASCADE MVP®

Elegantly simple and easy to use, with 0% major complications in 1,223 patients in 5 EP clinical trials.^3-7

Learn More

Performance Guarantee

We offer a unique value-based and risk-sharing purchasing program called the VASCADE^® Performance Guarantee.

Learn More

Fellows Development

An educational forum for Electrophysiology, Interventional Cardiology, Interventional Radiology, and Vascular Surgery fellows to increase their awareness and share best practices related to vascular closure. Our goal is to help fellows hone their vascular closure skills.

Learn More

Same Day Discharge

Electrophysiologists across the nation are achieving early ambulation and implementing same day discharge programs using the VASCADE MVP^® system. Read the latest clinical publications and hear from other EP physicians in our Same Day Discharge webinars and presentations.

Learn More

1. Hermiller JB, et.al. A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients Journal of Invasive Cardiology 2015;27(3):129-136.

2. IFUs and / or SSEDs of commercially available leading brands (VASCADE^®, AngioSeal^®, Mynx^®, Perclose™, Starclose™, Exoseal^®).

3. Natale A, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: The AMBULATE Trial. JACC Clin Electrophysiol 2020; 6(1):111-124.

4. Al-Ahmad A, et al. Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the mid-bore venous vascular closure system. VASCADE MVP following multi-access cardiac ablation procedures. J Cardiovasc Electrophysiol 2021. 32(2): 191-99.

5. AMBULATE Same Day Discharge Registry Retrospective Study: NCT04538781.

6/7. Eldadah ZA, et al. Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A post-market registry. J Cardiovasc Electrophysiol 2022. https://doi.org/10.1111/jce.15763 NCT04203329.

LIT 5832 REV AB

Vascular Closure

VASCADE®

VASCADE MVP®

Performance Guarantee

Fellows Development

Same Day Discharge

Connect with Vascular Closure